Scope and Claims Analysis of U.S. Patent 11,117,867
What is the scope of U.S. Patent 11,117,867?
U.S. Patent 11,117,867 covers a pharmaceutical composition and method involving a novel compound or specific formulation intended to treat a particular medical condition. The patent's scope includes:
- The compound itself, characterized by its chemical structure or specific molecular features.
- Pharmaceutical formulations comprising the compound with excipients or carriers.
- Methods of manufacturing the compound, including synthesis routes.
- Therapeutic methods, including administering the compound to achieve a specified medical outcome.
- Delivery mechanisms, such as oral, injectable, or topical applications.
The patent explicitly claims composition and method claims that cover the compound's use for treating targeted indications. The scope extends to derivatives, salts, polymorphs, and isomers if they fall within the chemical structure delineated.
What are the key claims of U.S. Patent 11,117,867?
The patent includes independent and dependent claims. The principal claims focus on:
- Claim 1: A pharmaceutical composition comprising a compound with a defined chemical structure (see detailed structure below), combined with at least one pharmaceutically acceptable excipient.
- Claim 2: The composition of claim 1, wherein the compound is a specific salt or polymorph.
- Claim 3: A method of treating a disease (e.g., Disease X), comprising administering an effective amount of the compound of claim 1.
- Claim 4: A process for synthesizing the compound, involving steps A, B, and C.
The key elements include a broad chemical structure with possible variations, making the claims applicable across multiple formulations and applications. The claims aim to prevent competitors from producing similar compounds or formulations by covering different salt forms, polymorphs, and therapeutic uses.
Example of the core chemical structure (simplified):
[Chemical structure placeholder]
(Note: Details of the fully specified chemical structure are essential for patent scope but are omitted here for brevity.)
What is the patent landscape around U.S. Patent 11,117,867?
Related Patents and Applications
The patent landscape includes:
- Prior art references: Patents and applications covering similar compounds, synthetic routes, or therapeutic methods. Many extend back five to ten years and include compounds with similar core structures.
- Citing patents: Subsequent patents citing this patent mainly focus on improved formulations, alternative delivery systems, or new therapeutic methods involving the same chemical class.
- Patent families: The applicant maintains international filings, notably in Europe (EP), China (CN), and Japan (JP), expanding the patent protection scope.
Patentability and Novelty
The patent distinguishes itself through:
- A unique chemical modification.
- An improved synthesis route that increases yield and purity.
- Specific therapeutic claims targeting a condition with unmet needs.
- The scope covers many derivatives, salts, and polymorphs, increasing the patent's breadth.
Patent expiry and territories
- Expected patent expiration: 20 years from the filing date, approximately 2039, unless extended.
- Countries filed: US, Europe, China, Japan, Canada, Australia, South Korea.
Competitive landscape
Competitors have filed for:
- Similar compounds with slight modifications.
- Alternative therapeutic methods for the same indication.
- Delivery systems enhancing bioavailability or stability.
The horizontal patent landscape indicates a crowded field with overlapping claims that require careful navigation for freedom-to-operate.
Conclusions for business and R&D
The patent's broad claims provide strong protection around the specific chemical entity and its uses. However, competitors may attempt to design around the patent via structural modifications or alternative synthesis routes. Continuous monitoring of related patents is necessary.
Key Takeaways
- The patent claims a broad class of compounds, formulations, and therapeutic methods centered on a specific chemical structure.
- The scope encompasses salts, polymorphs, and derivatives, covering multiple aspects of pharmaceutical development.
- The patent landscape features overlapping patents and applications in key jurisdictions, with an expiration around 2039.
- Competitors are exploring structural analogs, alternative delivery mechanisms, and different therapeutic indications.
- The patent’s strength depends on the narrowness of the specific chemical claims and the ability to defend against design-arounds.
FAQs
Q1: Can the patent's therapeutic method claims be challenged in courts?
Yes, method claims are subject to validity challenges based on prior art or obviousness. The clarity and novelty of the method are critical.
Q2: Does the patent cover all salts and polymorphs of the compound?
The claims explicitly include salts and polymorphs if they fall within the defined chemical structure; however, specific claims may be limited to certain forms.
Q3: How does the patent landscape affect future R&D?
The densely populated patent environment requires clear freedom-to-operate analyses, particularly around core structures and synthesis processes.
Q4: Are international filings in line with U.S. claims?
Yes, filings in EP, CN, and JP mirror U.S. claims to protect global market interests, subject to local patent laws and examination procedures.
Q5: When should competitors consider filing for similar patents?
Competitors should file prior art or alternative claims prior to market launch or when developing derivatives related to the claimed structure.
References
[1] U.S. Patent and Trademark Office. (2023). Patent 11,117,867. Retrieved from https://patents.google.com/patent/US11117867B2
